PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron
Clinical trial NCT00037882 · TERMINATED
Trial details
- NCT number
- NCT00037882
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2003-12-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.